Tuberculosis Vaccine
Dendritic cell vaccine is more potent T cell activator than protein-loaded counterparts
Published in Vaccine Weekly, June 7th, 2006
"Genetically modified dendritic cell (DC)-based vaccines have not been explored for immunization against tuberculosis. A gene-modified DC vaccine expressing Mycobacterium tuberculosis (M.tb) antigen 85A (Ag85A) was developed by using a recombinant replication-deficient adenoviral gene transfer vector (AdAg85A)," scientists in Canada report.
"AdAg85A-transduced DC vaccine (AdAg85/DC) expressed higher levels of IL-12 and was much more immunogenic than Ag85 protein-loaded (pro/DC) or CD4/CD8 T cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-06-07)
More Articles from Vaccine Weekly
- Lymphoma Vaccine
Idiotype vaccine elicits immune responses in B cell lymphoma despite immunosuppression - Rotavirus Vaccine
Rotavirus virus-like particles protect against rotavirus infection - SARS Vaccine
Membrane protein expression augments SARS DNA vaccine responses - SARS Vaccine
SARS coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies - Apoptosis
Neuronal apoptosis is more strongly induced by less neurovirulent rabies vaccine strain - Avian Influenza
Infants or adults? U.S. NIH ethicists argue for new avian influenza priorities - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
